About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
26 Sep 2019
Corporate Governance Statement
26 Sep 2019
Section 708 Certificate
26 Sep 2019
Appendix 3B
26 Sep 2019
Noxopharm 2019 Annual Report
24 Sep 2019
Departure of Dr Van Wyk
17 Sep 2019
Veyonda and Radiotherapy Profiled at Key Oncology Meeting
16 Sep 2019
Results of Meeting
16 Sep 2019
NOX EGM Chairman's Address and Presentation
12 Sep 2019
CHANGE OF DIRECTOR'S INTEREST NOTICE - GK
10 Sep 2019
CHANGE OF DIRECTOR'S INTEREST NOTICE - GK
Previous
1
2
3
4
5
6
7
8
9
10
11
Next
